MEP9309A - Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same - Google Patents

Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same

Info

Publication number
MEP9309A
MEP9309A MEP-93/09A MEP9309A MEP9309A ME P9309 A MEP9309 A ME P9309A ME P9309 A MEP9309 A ME P9309A ME P9309 A MEP9309 A ME P9309A
Authority
ME
Montenegro
Prior art keywords
pharmaceutical compositions
compositions containing
preparation
same
novel oligosaccharides
Prior art date
Application number
MEP-93/09A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Pierre Mourier
Elisabeth Perrin
Christian Viskov
Jean-Marie Stutzmann
Florence Wahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of MEP9309A publication Critical patent/MEP9309A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Psychology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • AIDS & HIV (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
MEP-93/09A 1999-10-22 2000-10-18 Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same MEP9309A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9913182A FR2800074B1 (fr) 1999-10-22 1999-10-22 Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
PCT/FR2000/002897 WO2001029055A2 (fr) 1999-10-22 2000-10-18 Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
MEP9309A true MEP9309A (en) 2011-12-20

Family

ID=9551218

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-93/09A MEP9309A (en) 1999-10-22 2000-10-18 Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same

Country Status (31)

Country Link
EP (1) EP1226148B1 (sh)
JP (1) JP4733329B2 (sh)
KR (2) KR100778166B1 (sh)
CN (1) CN1241932C (sh)
AT (1) ATE534656T1 (sh)
AU (1) AU781414B2 (sh)
BR (1) BR0014939A (sh)
CA (1) CA2388369C (sh)
CY (1) CY1112274T1 (sh)
CZ (1) CZ303255B6 (sh)
DK (1) DK1226148T3 (sh)
EA (1) EA004046B1 (sh)
EE (1) EE05091B1 (sh)
ES (1) ES2376409T3 (sh)
FR (1) FR2800074B1 (sh)
HK (1) HK1050535A1 (sh)
HR (1) HRP20020330A2 (sh)
HU (1) HU229385B1 (sh)
IL (2) IL149154A0 (sh)
ME (1) MEP9309A (sh)
MX (1) MXPA02003945A (sh)
NO (1) NO323409B1 (sh)
NZ (1) NZ518539A (sh)
PL (1) PL204623B1 (sh)
PT (1) PT1226148E (sh)
RS (1) RS50829B (sh)
SK (1) SK287459B6 (sh)
TR (1) TR200201102T2 (sh)
UA (1) UA72545C2 (sh)
WO (1) WO2001029055A2 (sh)
ZA (1) ZA200203102B (sh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4676048B2 (ja) * 2000-07-10 2011-04-27 生化学工業株式会社 脱髄性疾患処置剤
MXPA03004965A (es) * 2000-12-16 2003-09-25 Aventis Pharma Gmbh El uso de heparina de bajo peso molecular para el tratamiento de osteoartrosis.
DE10121003A1 (de) 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
FR2844808B1 (fr) * 2002-09-23 2005-02-25 Aventis Pharma Sa Methode de determination de groupements specifiques constituant les heparines ou les heparines de bas poids moleculaire
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
EP1580197A1 (en) * 2004-03-24 2005-09-28 Aventis Pharma S.A. Method for quantitatively determining specific groups constituting heparins or low molecular wieght heparins using HPLC
DE102005017799A1 (de) * 2005-04-18 2006-10-19 Abbott Gmbh & Co. Kg Verwendung von Heparin und Heparinderivaten zur Modulation des Neuritenwachstum-kontrollierenden Nogo-Rezeptors
US8101733B1 (en) 2006-06-27 2012-01-24 Momenta Pharmaceuticals, Inc. Methods of evaluating mixtures of polysaccharides
US7790466B1 (en) 2007-01-26 2010-09-07 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
US7968082B1 (en) 2007-01-26 2011-06-28 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by NMR
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2256138A1 (en) 2009-05-05 2010-12-01 Sanofi-Aventis Novel acylated 1,6-anhhydro decasaccharide and its use as antithrombotic agent
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) * 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
CN102791742B (zh) 2010-01-19 2014-12-24 动量制药公司 评价肝素制剂
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102864191A (zh) * 2011-12-16 2013-01-09 深圳市海普瑞药业股份有限公司 肝素双糖混合物及其制备方法和应用
CN104910217B (zh) * 2015-06-19 2018-04-17 天津红日药业股份有限公司 用于磺达肝癸钠质量控制的参比化合物
CZ308106B6 (cs) * 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
CN110092848A (zh) * 2019-05-14 2019-08-06 山东辰龙药业有限公司 一种贝米肝素钠的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519987A1 (fr) * 1982-01-15 1983-07-22 Choay Sa Trisaccharides a structures d-glucosamine, acide d-glucuronique, d-glucosamine et leur preparation
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
JP4166851B2 (ja) * 1997-09-29 2008-10-15 生化学工業株式会社 新規虚血・再灌流障害抑制剤

Also Published As

Publication number Publication date
SK287459B6 (sk) 2010-10-07
SK5272002A3 (en) 2002-08-06
EP1226148B1 (fr) 2011-11-23
EA200200479A1 (ru) 2002-10-31
NO323409B1 (no) 2007-04-30
IL149154A (en) 2008-04-13
KR20020063881A (ko) 2002-08-05
HUP0203821A3 (en) 2003-10-28
CA2388369C (fr) 2011-02-01
AU7930200A (en) 2001-04-30
JP4733329B2 (ja) 2011-07-27
AU781414B2 (en) 2005-05-19
WO2001029055A3 (fr) 2002-02-14
NZ518539A (en) 2004-10-29
CA2388369A1 (fr) 2001-04-26
KR100872215B1 (ko) 2008-12-05
ZA200203102B (en) 2003-09-23
PT1226148E (pt) 2012-01-24
WO2001029055A2 (fr) 2001-04-26
EE05091B1 (et) 2008-10-15
BR0014939A (pt) 2002-06-18
UA72545C2 (uk) 2005-03-15
RS50829B (sr) 2010-08-31
CN1379781A (zh) 2002-11-13
EP1226148A2 (fr) 2002-07-31
NO20021859D0 (no) 2002-04-19
YU29802A (sh) 2006-01-16
HRP20020330B1 (sh) 2013-01-31
MXPA02003945A (es) 2002-10-23
HK1050535A1 (en) 2003-06-27
KR20070087263A (ko) 2007-08-27
KR100778166B1 (ko) 2007-11-27
HUP0203821A2 (hu) 2003-04-28
JP2003512385A (ja) 2003-04-02
ES2376409T3 (es) 2012-03-13
HU229385B1 (en) 2013-11-28
HRP20020330A2 (en) 2004-04-30
CZ303255B6 (cs) 2012-06-27
ATE534656T1 (de) 2011-12-15
DK1226148T3 (da) 2012-03-19
EE200200208A (et) 2003-06-16
FR2800074B1 (fr) 2001-12-21
PL204623B1 (pl) 2010-01-29
FR2800074A1 (fr) 2001-04-27
NO20021859L (no) 2002-06-13
PL363052A1 (en) 2004-11-15
CY1112274T1 (el) 2015-12-09
CZ20021385A3 (cs) 2002-07-17
IL149154A0 (en) 2002-11-10
TR200201102T2 (tr) 2002-12-23
CN1241932C (zh) 2006-02-15
EA004046B1 (ru) 2003-12-25

Similar Documents

Publication Publication Date Title
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
HRP20041042A2 (en) Novel substituted sulfamate anticonvulsant derivatives
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
SE9904505D0 (sv) Novel compounds
YU46903A (sh) Derivati difenil-azetidinona,postupak za njihovu proizvodnju lekovi koji sadrže ova jedinjenja i njihova primena
YU47803A (sh) Derivati difenil-azetidinona, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
FI954898A (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
ES2243579T3 (es) Derivados de pirazolopirideno.
YU56302A (sh) Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva
YU94103A (sh) Novi derivati sulfonske kiseline
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
BR0112043A (pt) Ftalidas substituìdas, processo para sua preparação e composições farmacêuticas contendo-as
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
IL98970A0 (en) Cyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CY1112050T1 (el) Νεα 2-αλογονοποιημενα παραγωγα της 5-0- δεσοσαμινυλερυθρονολιδης α, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
YU37597A (sh) Novi derivati piranozida
FR2756826B1 (fr) Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EA200000389A3 (ru) Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции
SG146627A1 (en) Imidazole derivatives
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
YU74401A (sh) Postupak za dobijanje 2s-3-amino-3-arilpropionske kiseline i njenih derivata
ATE446952T1 (de) Herstellungsverfahren von 2-cyanopyridinen